PhaseBio Pharmaceuticals Inc (PHASQ)

[Whalatane]

It’s the FDA approval for the Covid indication .
RLFTF has already been granted FDA fast track status and an Orphan drug designation

Therefore if their version of VIP gets approved first .... they have the market to themselves for a min of 3 yrs ... new indication exclusivity for an existing drug .... and possibly longer

Is your VIP version isn’t fast tracked then it’s unlikely to beat RLFTF in getting approved ( assuming trials succeed )

Kiwi